Integral Health Asset Management, LLC Atara Biotherapeutics, Inc. Transaction History

Integral Health Asset Management, LLC

  • $1.06 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022
SELL
$4.69 - $9.84 $428,018 - $898,018
-91,262 Reduced 30.42%
208,738 $1.63 Million
Q1 2022

May 12, 2022
BUY
$8.44 - $16.89 $844,000 - $1.69 Million
100,000 Added 50.0%
300,000 $2.79 Million
Q3 2021

Nov 12, 2021
BUY
$11.99 - $17.9 $2.4 Million - $3.58 Million
200,000 New
200,000 $3.58 Million

Others Institutions Holding ATRA

# of Institutions
87
Shares Held
85M
Call Options Held
18.4K
Put Options Held
51.3K
View Full List

About Atara Biotherapeutics, Inc.

ATRA Quotes by TradingView
  • Ticker ATRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,362,304
  • Market Cap $728M
  • Description
  • Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...
More about ATRA
Track This Portfolio

Track Integral Health Asset Management, LLC Portfolio

Follow Integral Health Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integral Health Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email